Actionable news
All posts from Actionable news
Actionable news in PRPO: Precipio Inc,

Precipio, Inc.

Transgenomic, Inc. reports financial results for the quarter ended March 31, 2017.We analyze the earnings along side the following peers of Transgenomic, Inc. - Agilent Technologies, Inc. (A-US) that have also reported for this period.

  • Summary numbers: Revenues of USD 0.66 million, Net Earnings of USD -1.84 million.
  • Gross margins widened from -113.98% to 30.24% compared to the same period last year, operating (EBITDA) margins now -174.62% from -915.25%.
  • Year-on-year change in operating cash flow of 97.40% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
  • Earnings growth from operating margin improvements as well as one-time items.

The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth:

Revenues (mil)0.6580.3590.4570.5050.236
Revenue Growth (%YOY)178.80-88.5-92.8-96.4
Earnings (mil)-1.8-2.1-1.9-2.2-2.1
Earnings Growth (%YOY)12.2-1527733.531.2
Net Margin (%)-278.9-586.9-414-431.5-886
Return on Equity (%)N/AN/AN/AN/AN/A
Return on Assets (%)-590-505.1-292.7-260.7-197.8

Access our Ratings and Scores for Transgenomic, Inc.

Click here to view



PRPO-US's change in revenue this period compared to the same period last year of 178.81% is almost the same as its change in earnings, and is about average among the announced results thus far in its peer group, suggesting that PRPO-US is holding onto its market share. Also, for comparison purposes, revenues changed by 83.29% and earnings by 12.91% compared to the immediate last period.Spreadsheet

A-USA-USPRPO-USPRPO-USLeaderLeaderEarnings FocusEarnings FocusLaggardLaggardRevenues FocusRevenues Focus

The company's earnings growth was influenced by year-on-year improvement in gross margins from -113.98% to 30.24% as well as better cost...